ADMA
Adma Biologics
$9.39
−$0.06 (−0.63%)Sep 10, 2026
Key metrics
The numbers that frame ADMA today
- Market cap
- $2.10B
- P/E (TTM)
- 12.4
- EV / FCF
- 18.6
- Gross margin
- 64.7%
- EV / Sales
- 4.2
- ROIC
- 38%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $7.21
- 52wk High
- $20.46
Growth
Revenue and earnings trend for ADMA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ADMA
Is Adma Biologics a good buy?
Yes. Adma Biologics has excellent quality, and it outweighs the poor momentum here. Growth looks strong, which supports the long-term business case. We think Adma Biologics is selling at a low price.
What is the market capitalization of ADMA?
Adma Biologics's market capitalization is $2.10B.
What is the P/E ratio for ADMA stock?
Adma Biologics's current P/E ratio is 12.4.
What is the 52-week high for ADMA stock?
The 52-week high for Adma Biologics is $20.46. The current close of $9.39 is 54.1% below that high.
What is the 52-week low for ADMA stock?
The 52-week low for Adma Biologics is $7.21. The current close of $9.39 is 30.2% above that low.
Does ADMA stock pay dividends?
Adma Biologics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ADMA?
Adma Biologics's Debt / Equity ratio is 0.48.